Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer
- 8 July 2008
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 63 (2) , 284-290
- https://doi.org/10.1016/j.lungcan.2008.05.024
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeting survivin in cancer therapyEmerging Therapeutic Targets, 2008
- The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literaturesLung Cancer, 2008
- Survivin: A promising tumor biomarkerCancer Letters, 2007
- Targeting survivin in cancer therapy: fulfilled promises and open questionsCarcinogenesis: Integrative Cancer Research, 2007
- Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISAClinical & Experimental Metastasis, 2006
- Development of a membrane array‐based multimarker assay for detection of circulating cancer cells in patients with non‐small cell lung cancerInternational Journal of Cancer, 2006
- Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)Lung Cancer, 2005
- The detection of circulating breast cancer cells in bloodJournal of Clinical Pathology, 2004
- Survivin gene expression in early‐stage non‐small cell lung cancerThe Journal of Pathology, 2003
- Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCRInternational Journal of Cancer, 2001